Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5841491 | Life Sciences | 2016 | 8 Pages |
Abstract
It appears that the antioxidant status is affected in PBMCs from MS patients and melatonin could improve impaired antioxidant defense in MS through upregulation of SIRT1, MnSOD and catalase, which might be important in MS management.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Solaleh Emamgholipour, Arash Hossein-nezhad, Mohammad Ali Sahraian, Fatemeh Askarisadr, Mohammad Ansari,